ACADIA Pharmaceuticals Inc (ACAD)
14.90
-0.20
(-1.32%)
USD |
NASDAQ |
May 21, 12:43
ACADIA Pharmaceuticals Total Liabilities (Quarterly): 391.06M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 391.06M |
December 31, 2023 | 317.20M |
September 30, 2023 | 270.37M |
June 30, 2023 | 246.98M |
March 31, 2023 | 281.05M |
December 31, 2022 | 187.40M |
September 30, 2022 | 176.80M |
June 30, 2022 | 177.92M |
March 31, 2022 | 179.45M |
December 31, 2021 | 159.23M |
September 30, 2021 | 150.72M |
June 30, 2021 | 159.59M |
March 31, 2021 | 173.57M |
December 31, 2020 | 155.61M |
September 30, 2020 | 140.80M |
June 30, 2020 | 96.64M |
March 31, 2020 | 109.07M |
December 31, 2019 | 84.05M |
September 30, 2019 | 76.30M |
June 30, 2019 | 71.97M |
March 31, 2019 | 82.75M |
December 31, 2018 | 61.12M |
September 30, 2018 | 43.02M |
June 30, 2018 | 50.24M |
March 31, 2018 | 46.87M |
Date | Value |
---|---|
December 31, 2017 | 49.22M |
September 30, 2017 | 36.39M |
June 30, 2017 | 41.18M |
March 31, 2017 | 45.49M |
December 31, 2016 | 42.74M |
September 30, 2016 | 39.33M |
June 30, 2016 | 29.22M |
March 31, 2016 | 21.34M |
December 31, 2015 | 22.13M |
September 30, 2015 | 17.97M |
June 30, 2015 | 19.72M |
March 31, 2015 | 16.87M |
December 31, 2014 | 15.97M |
September 30, 2014 | 11.27M |
June 30, 2014 | 9.357M |
March 31, 2014 | 8.046M |
December 31, 2013 | 6.987M |
September 30, 2013 | 18.53M |
June 30, 2013 | 25.43M |
March 31, 2013 | 23.35M |
December 31, 2012 | 23.61M |
September 30, 2012 | 6.086M |
June 30, 2012 | 9.166M |
March 31, 2012 | 8.934M |
December 31, 2011 | 8.752M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
71.97M
Minimum
Jun 2019
391.06M
Maximum
Mar 2024
180.29M
Average
166.58M
Median
Total Liabilities (Quarterly) Benchmarks
Regulus Therapeutics Inc | 6.55M |
Amylyx Pharmaceuticals Inc | 93.02M |
Alnylam Pharmaceuticals Inc | 4.044B |
Cassava Sciences Inc | 77.12M |
Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 855.10M |
Shareholders Equity (Quarterly) | 464.04M |
Current Ratio | 2.043 |